Company / CapEx per Share
ADMA Biologics, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.10
FY2025
5-year range
$0.02 / $0.13
FY2021-FY2025
Trend
+162.2%
vs FY2024
Sector context
#59 of 192
Health Care
What the data says
At $0.10, ADMA Biologics, Inc.'s capex per share ranks #59 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 10 years, ranging from $0.01 in FY2017 to $0.21 in FY2020.
Based on SEC 10-K filings.
0.10 in FY2025 with a 5-year CAGR of -15.0%.
Improved from $0.02 to $0.10 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +11.4%
- 5-Year CAGR
- -15.0%
- 10-Year CAGR
- -
Sector benchmark
#59 of 192 in Health CareTop 31% of 192This company $0.10 Sector average $2.46
▼
-96.1% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 162.2% year-over-year.
- Ranks #59 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2020.
- Lowest capex per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | +162.2% |
| FY2024 | $0.04 | +69.2% |
| FY2023 | $0.02 | -68.8% |
| FY2022 | $0.07 | -46.4% |
| FY2021 | $0.13 | -40.0% |
| FY2020 | $0.21 | +160.9% |
| FY2019 | $0.08 | +44.1% |
| FY2018 | $0.06 | +901.7% |
| FY2017 | $0.01 | -16.9% |
| FY2016 | $0.01 | -97.3% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026